- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Severe Photo Toxicity Recalled by Docetaxel ; volume:11 ; number:3 ; year:2018 ; pages:751-755
Case reports in oncology ; 11, Heft 3 (2018), 751-755
- Urheber
-
Johansson, Emma K.
Krynitz, Britta
Holmsten, Magnus
Klockhoff, Kerstin
Isaksson Friman, Erika
Xie, Hanjing
- DOI
-
10.1159/000494208
- URN
-
urn:nbn:de:101:1-2019010923234662375396
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Johansson, Emma K.
- Krynitz, Britta
- Holmsten, Magnus
- Klockhoff, Kerstin
- Isaksson Friman, Erika
- Xie, Hanjing
Ähnliche Objekte (12)
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
Comparative In Vitro Toxicity Study of Docetaxel and Nanoxel, a Docetaxel-Loaded Micellar Formulation Using Cultured and Blood Cells
Severe synergistic toxicity from docetaxel in a patient treated concurrently with protease inhibitors as part of HIV post-exposure prophylaxis: a case report
Synthesis, characterization and controlled toxicity of a novel hybrid material based on cisplatin and docetaxel
Severe carvedilol toxicity without overdose – caution in cirrhosis
Esophagitis dissecans superficialis due to severe methotrexate toxicity
Severe skin toxicity due to weekly paclitaxel administration
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
Comparative In Vitro Toxicity Study of Docetaxel and Nanoxel, a Docetaxel-Loaded Micellar Formulation Using Cultured and Blood Cells
Severe synergistic toxicity from docetaxel in a patient treated concurrently with protease inhibitors as part of HIV post-exposure prophylaxis: a case report
Synthesis, characterization and controlled toxicity of a novel hybrid material based on cisplatin and docetaxel
Severe carvedilol toxicity without overdose – caution in cirrhosis
Esophagitis dissecans superficialis due to severe methotrexate toxicity
Severe skin toxicity due to weekly paclitaxel administration
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
Comparative In Vitro Toxicity Study of Docetaxel and Nanoxel, a Docetaxel-Loaded Micellar Formulation Using Cultured and Blood Cells
Severe synergistic toxicity from docetaxel in a patient treated concurrently with protease inhibitors as part of HIV post-exposure prophylaxis: a case report
Synthesis, characterization and controlled toxicity of a novel hybrid material based on cisplatin and docetaxel
Severe carvedilol toxicity without overdose – caution in cirrhosis
Esophagitis dissecans superficialis due to severe methotrexate toxicity
Severe skin toxicity due to weekly paclitaxel administration
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel